Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING
PZ HTL SA

Collaboration to Advance Data Visualization and Discovery Platform

By BiotechDaily International staff writers
Posted on 02 Oct 2012
PerkinElmer, Inc. (Waltham, MA, USA) and Tibco Software, Inc. (Palo Alto, CA, USA), the provider of Tibco Spotfire, a leading analytics and data discovery platform, announced that they have entered into an exclusive strategic relationship.

Under the terms of this new agreement, PerkinElmer has licensed the exclusive, worldwide rights to the Tibco Spotfire software platform in specific scientific research and development markets. These markets include basic and preclinical development applications in life sciences as well as R&D, quality assurance and quality control applications in chemical, petrochemical, environmental, food and beverage, consumer products, and academia.

This alliance will combine the depth and strength of PerkinElmer’s domain knowledge and systems with the analytic capabilities of Tibco Spotfire to provide a broader, richer set of analytic solutions for the research market. As a result, PerkinElmer will take responsibility for growing and servicing the Tibco Spotfire business in these markets.

“How scientists capture and visualize their data through the Tibco Spotfire platform is fundamental to how scientists conduct their work. Spotfire is a critical data analysis tool for the R&D community and complements PerkinElmer’s informatics offering by adding search and data visualization, which are among the most pressing business requirements of life sciences, diagnostics and environmental laboratories, worldwide,” said Mike Stapleton, general manager of informatics at PerkinElmer. “Through this strategic relationship, we are very excited to offer scientists a complete package of data generation, data management as well as data analysis and visualization to better harness information for more informed insights and decisions. The interoperability of PerkinElmer’s E-Notebook with the Tibco Spotfire platform puts all information in one place for our customers.”

One of the biggest hurdles for scientists now is the volume and diversity of data they need to gather and study to make knowledgeable and informed decisions that impact both research and business intelligence efforts. The Tibco Spotfire platform helps complete the analysis workflow by adding real time data interpretation to existing data generation and assembly tools. The data visualization tool enables researchers to instantly visualize and share data across an enterprise to reveal opportunities, avoid risks, and anticipate trends. This system can be applied to nearly every type of science and can analyze data from virtually any instrument platform.

“This new relationship is exciting news for research scientists. Our relationship with PerkinElmer will enable a broader community to benefit from the Tibco Spotfire platform and will expand the range and depth of applications serving the rapidly evolving needs of scientific research,” said Christian Marcazzo, co-head of global life sciences for Spotfire at Tibco Software Inc.

PerkinElmer is a provider of discovery, collaboration, and knowledge enterprise solutions, desktop software, scientific databases, and consulting services to the pharmaceutical, biotechnology, and chemical industries. The Company offers enterprise solutions, desktop software, scientific databases, and professional services for biotechnology, drug discovery and chemical research, including software, databases, and web sites that enable customers to create, analyze, and communicate chemical, biologic, and scientific data more effectively. The company reported revenue of approximately USD 1.9 billion in 2011, has approximately 7,000 employees serving customers in more than 150 countries.

Tibco Software is a provider of infrastructure software for companies to use on-premise or as part of cloud computing environments. Tibco Spotfire is the company’s in-memory analytics software for next-generation business intelligence. By offering a visual, interactive experience, Spotfire helps professionals rapidly discover new and actionable insights in information.

Related Links:

PerkinElmer
Tibco



Channels

Genomics/Proteomics

view channel
Image: The TheraCyte cell encapsulation device (Photo courtesy of TheraCyte, Inc.).

Encapsulated Human-Insulin-Producing Progenitor Cells Cure Diabetes in Mouse Model

A breakthrough system that allows subcutaneous implantation of encapsulated immature pancreatic cells (beta progenitor cells) was shown to produce enough insulin to correct the symptoms of diabetes in a mouse model.... Read more

Drug Discovery

view channel

Retinoic Acid Prevents Precancerous Breast Cells from Progressing to Full-Blown Cancer

Retinoic acid, a derivative of vitamin A, was found to prevent pre-cancerous breast cells from progressing to full-blown cancer but did not have any effect on breast tumor cells. Investigators at Thomas Jefferson University (Philadelphia, PA, USA) worked with a novel breast cancer model that had been developed by treating... Read more

Biochemistry

view channel

Mitochondrial Cause of Aging Can Be Reversed

Researchers have found a cause of aging in lab animals that can be reversed, possibly providing an avenue for new treatments for age-related diseases including type 2 diabetes, cancer, muscle wasting, and inflammatory diseases. The researchers plan to begin human trials late 2014. The study, which was published December... Read more

Therapeutics

view channel

Cytokine Identified That Causes Mucositis in Cancer Therapy Patients

The action of the cytokine interleukin 1-beta (IL-1beta) has been found to underlie the onset of mucositis, a common, severe side effect of chemotherapy and irradiation of cancer patients. Mucositis occurs as a result of cell death in reaction to chemo- or radiotherapy. The mucosal lining of the mouth becomes thin, may... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.